U.S. Insurance Stock News

Viking Therapeutics (NasdaqCM:VKTX) has advanced its obesity drug candidate VK2735 into Phase 3 development following FDA feedback. Enrollment for the pivotal subcutaneous Phase 3 trials, VANQUISH-1 and VANQUISH-2, is reported to be nearly complete. The company has also started a new maintenance and transition study for the oral version of VK2735, with readouts expected later this year. Viking Therapeutics focuses on metabolic and endocrine disorders, and VK2735 sits at the center of its...

If you are wondering whether Gilat Satellite Networks at US$16.98 is still offering value after a strong run, this article will help you break that question down step by step. The stock has pulled back with a 3.6% decline over the past week and an 11.9% decline over the past month. It also shows a 26.6% return year to date, 140.2% over 1 year, 205.9% over 3 years and 31.9% over 5 years, which may catch the eye of investors thinking about growth potential and shifting risk perceptions. Recent...

If you are wondering whether General Mills is starting to look like value territory after a rough patch, this article will walk through what the current share price might be implying. The stock closed at US$40.66, with returns of a 6.7% decline over 7 days, a 15.5% decline over 30 days and an 11.1% decline year to date, contributing to a 28.9% decline over 1 year, a 43.5% decline over 3 years and an 18.2% decline over 5 years. Recent news around General Mills has largely focused on its...

If you are wondering whether Pool's current share price lines up with its underlying worth, you are not alone. This article is built to help you size up what you are really paying for. Pool's stock recently closed at US$210.88, with returns of a 4.3% decline over 7 days, a 19.7% decline over 30 days, an 8.2% decline year to date, a 35.5% decline over 1 year, a 36.3% decline over 3 years, and a 33.8% decline over 5 years, which may have shifted how investors think about its risk and...

Earlier in March 2026, Pfizer reported positive Phase 2 results for its investigational trispecific antibody tilrekimig in adults with moderate to severe atopic dermatitis, showing statistically significant EASI-75 responses versus placebo with a favorable safety profile across multiple monthly dosing regimens. The data suggest tilrekimig could emerge as a differentiated, once-monthly option across several Type 2 inflammatory diseases, reinforcing Pfizer’s push into higher-value immunology...

MercadoLibre (NasdaqGS:MELI) announced a record US$3.4b investment in Argentina. The company plans to create 2,000 new jobs in the country. The new investment represents a 30% year over year increase. MercadoLibre runs a large e commerce and fintech ecosystem across Latin America, and Argentina is its home market. This new spending plan points to a focus on logistics infrastructure, technology development, and financial services that support both merchants and consumers. For investors, the...

Why Gilead Sciences (GILD) is on investors’ radar today Gilead Sciences (GILD) has drawn fresh attention after recent share price moves, including a return of about 20% over the past 3 months and roughly 32% over the past year. For a large biopharmaceutical company with annual revenue of about US$29.4b and net income around US$8.5b, that kind of multi period performance often prompts investors to reassess what is already priced into the stock. See our latest analysis for Gilead...

Otis Worldwide (NYSE:OTIS) has launched its Otis Viva solutions to address accessibility and mobility challenges for aging populations. The new offering focuses on elevator safety, reliability, and accessibility for older adults, and can be applied to both upgrades of existing systems and new installations. Otis Worldwide, known for elevators, escalators, and related services, is using Viva to speak directly to aging population trends and growing interest in inclusive building design. For...

Colgate-Palmolive (CL) is back on many investors’ screens after recent share price moves, including a roughly 3% decline over the past week and a 5% pullback over the past month. See our latest analysis for Colgate-Palmolive. Zooming out, the recent 1 day share price drop of 3.11% and 7 day share price decline of 5.95% come after a stronger 90 day share price return of 16%, with a 1 year total shareholder return of 1.10% suggesting momentum has cooled recently. If this defensive consumer name...

If you are wondering whether MGE Energy at around US$74 is a fair deal or not, this article is here to unpack what the current price might be telling you about value. The stock has seen some pressure recently, with a 7 day return of 8.6% decline adding to 30 day and 1 year returns of 5.8% decline and 16.6% decline, while the 3 year and 5 year returns sit at 4.6% and 16.5% respectively. Recent attention around MGE Energy has focused on its role as a regulated utility and how investors view...

In early March 2026, Stripe announced it had expanded its long-standing partnership with Affirm to support Shared Payment Tokens, enabling AI agents to initiate BNPL-powered purchases using shoppers’ preferred payment methods without exposing sensitive credentials, while Stripe processes transactions between merchants and Affirm on the backend. This move extends Affirm’s transaction-based, pay-over-time model into emerging AI-driven commerce channels, allowing merchants to present...

If you are trying to figure out whether Webull is starting to look like value or still carries too much risk, focusing on what the current price actually reflects can help you frame your next move. Webull's share price closed at US$5.48, with returns of a 9.7% decline over the last 7 days, a 19.3% decline over 30 days, a 33.1% decline year to date, a 53.2% decline over 1 year and a 47.4% decline over 3 years, which raises questions about how the market is currently pricing its...

Shoppers who had been boycotting Target over its diversity, equity, and inclusion policies are signaling an end to their protest. Activist groups say Target has acknowledged a breakdown in trust with the Black community and has taken steps that point to a thaw in relations. This shift marks a change in stakeholder sentiment around NYSE:TGT that has affected sales and public perception in recent years. For you as an investor following NYSE:TGT, this development sits on top of Target's core...

ServiceNow (NYSE:NOW) has partnered with Aiva Health to bring voice driven AI into healthcare operations, enabling real time, voice activated workflow automation for clinicians. The company has also teamed up with Cohesity to offer end to end agent resilience for autonomous enterprise AI agents and data protection. These moves extend ServiceNow's AI presence in regulated sectors like healthcare and reinforce its role as an AI control tower for enterprise workflows. For investors watching...

Why Trade Desk (TTD) May Be On Your Radar Today Trade Desk (TTD) has drawn attention after a period where the share price has moved in different directions over short and longer time frames, prompting investors to reassess how its current valuation aligns with recent performance. See our latest analysis for Trade Desk. Recently, Trade Desk has seen a mix of short term strength and longer term weakness, with an 8.38% 7 day share price return contrasting with a 27.60% year to date share price...

Dollar Tree is rolling out a multi price strategy, with items now offered at price points up to $7. The company reports 3 million more households shopped at its stores this quarter compared with the prior year. Roughly 60% of these new shoppers come from households earning over $100,000, signaling a shift in its customer base. For investors watching NasdaqGS:DLTR, this shift in who shops at Dollar Tree comes as the stock trades around $113.25. The share price is up 82.9% over the past year,...

Earlier this week, Ferguson Enterprises reported strong recent financial results and reiterated positive guidance for fiscal 2026, but highlighted ongoing softness in its U.S. residential markets and a 1% decline in HVAC revenues driven by affordability challenges and tough comparisons. The company’s cautious outlook for only low to mid-single-digit net sales growth and adjusted operating margins drew attention to how pockets of housing-related weakness can weigh on sentiment even when...

Merck (NYSE:MRK) reported landmark Phase 3 results for KEYTRUDA and WELIREG-based regimens in renal, ovarian, and bladder cancers over the past two weeks. KEYTRUDA combinations showed significant benefits in advanced renal cell carcinoma and muscle-invasive bladder cancer in late-stage trials presented at major oncology congresses, including ASCO GU. WELIREG-based regimens delivered positive Phase 3 data in platinum-resistant recurrent ovarian cancer, with first-time disclosures at...

What recent returns say about Marvell Technology (MRVL) With no single headline event driving attention to Marvell Technology (MRVL) today, investors may instead focus on how the stock has traded recently and how that lines up with the company’s current fundamentals. Over the past week, Marvell’s share price has moved by about 16%, with a smaller gain over the past month and a modest positive return over the past 3 months. Those moves sit against a last close of US$90.44 and a value score of...

If you are looking at Carnival Corporation & and wondering whether the current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. The stock last closed at US$25.97, with returns of 33.8% over 1 year and 198.9% over 3 years, even as the 7 day, 30 day and year to date returns of 7.3%, 20.8% and 16.0% declines hint at changing sentiment and risk perceptions. Recent attention on Carnival has focused on how cruise operators fit...

Earnings call puts Talos Energy (TALO) cash generation and project progress in focus Talos Energy (TALO) drew fresh attention after its latest earnings call, where management discussed cash generation, capital returns, Gulf of America project updates, and production challenges linked to planned downtime and a major well outage. See our latest analysis for Talos Energy. Talos Energy’s 1 day share price return of 3.79% following the earnings call adds to a 90 day share price return of 16.68%...

Trex Company (NYSE:TREX) has launched Trex Refuge, a fire-resistant decking line designed for high fire-risk regions. The product is engineered to meet Class A Flame Spread and ignition resistance standards for Wildland-Urban Interface zones. Trex Refuge comes with a 50-year residential warranty and targets homeowners and builders in fire-prone communities. Trex is rolling out Trex Refuge at a time when its shares trade at $38.16 and its 1 year return stands at a 30.6% decline. Over 5...

Earlier this week, a Form 4 filing showed Coty’s President of Consumer Beauty, Gordon von Bretten, bought 83,000 Coty shares on the open market, increasing his personal stake. This insider purchase, coming soon after Coty withdrew its FY26 guidance, challenges concerns about Consumer Beauty’s fundamentals and signals leadership’s conviction in the division’s turnaround efforts. We’ll now explore how this insider buying, coming after the FY26 guidance withdrawal, may influence Coty’s existing...

GE Aerospace (NYSE:GE) and Palantir Technologies announced a multi year expansion of their partnership to deploy advanced AI solutions. The collaboration targets the U.S. Air Force's aviation readiness and GE's own production system with agentic AI powered tools. The agreement extends prior work between the companies into a broader effort across defense operations and manufacturing. For investors tracking NYSE:GE, this AI focused update adds another angle to the story alongside recent...